Juliana da Rocha dos Santos

Short Bio

PhD student and Master from Faculty of Medicine, at the University of São Paulo - USP (2015) and graduated in Pharmacy from Mackenzie University (2011). In her master's project, performed in the Laboratory of Genetics and Molecular Cardiology, Heart Institute, at the University of São Paulo (InCor-HC / USP), she evaluated the effect of genetic polymorphisms on therapeutic response to drugs for smoking cessation. The research found association of two polymorphisms with improved therapeutic response to varenilcina (published in the Journal Frontiers in Genetics) and bupropion (published in the European Journal of Clinical Pharmacology), respectively; the study was commented in the newspaper Folha de São Paulo and in the Jornal da Band (in the television network Bandeirantes).

Line of Investigation

  • Pharmacogenetic avaliation in patients trated with drugs for smoking cessation

Publications

  1. TOMAZ, PAULO ROBERTO XAVIER;SANTOS, JULIANA ROCHA;ISSA, JAQUELINE SCHOLZ;ABE, TÂNIA OGAWA;GAYA, PATRÍCIA VIVIANE;KRIEGER, JOSÉ EDUARDO;PEREIRA, ALEXANDRE COSTA;SANTOS, PAULO CALEB JÚNIOR LIMA;.CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. European Journal of Clinical Pharmacology (Internet),v.71,1067/ 9 - 1073,2015;
  2. TOMAZ, PAULO ROBERTO XAVIER;SANTOS, J. R.;SANTOS, P. C. J. L.;.Aspectos da aplicabilidade da análise da curva de melting. Aspectos da aplicabilidade da análise da curva de melting,v.48,19 - 23,2016;
  3. ROCHA SANTOS, JULIANA;TOMAZ, PAULO R. X.;ISSA, JAQUELINE S.;ABE, TâNIA O.;KRIEGER, JOSé E.;PEREIRA, ALEXANDRE C.;SANTOS, PAULO C. J. L.;.CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy. Frontiers in Genetics,v.6,46,2015;